Form 4 for ACCO ACCO BRANDS Corp
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-28 · accession 0000712034-22-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-01 | 2022-02-28 | ACCO | Fenwick Neal V | CFO, Executive VP | M - OptEx | $7.51 | +66.3K | 679.1K | +11% | +$498.0K |
| D | 2022-03-01 | 2022-02-28 | ACCO | Fenwick Neal V | CFO, Executive VP | S - Sale+OE | $8.60 | -66.3K | 612.7K | -10% | -$570.3K |
| D | 2022-03-01 | 2022-02-28 | ACCO | Fenwick Neal V | CFO, Executive VP | M - OptEx | $0.00 | -66.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | M | A | 66,313 | $7.51 | 679,057 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2021. |
| 2 | Common | Common Stock | 2022-02-28 | S | D | 66,313 | $8.60 | 612,744 | D | — | — | (F2) This price reflects the weighted average sale price for the shares, which were sold in multiple transactions at prices that ranged from $8.52 to $8.70. Upon request of the SEC staff, the issuer, or a security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2021. |
| 3 | Derivative | Stock Option (right to buy) | 2022-02-28 | M | D | 66,313 | $0.00 | 0 | D | $7.51 · 2016-03-04 to 2022-03-04 | 66,313 Common Stock | (F3) Nonqualified employee stock options granted under the Issuer's Amended and Restated 2011 Incentive Plan. One-third of original grant vests annually. Options expire seven years from the grant date, if not earlier terminated or exercised in full, subject to acceleration as provided in said Plan. |